Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma
about
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumorIdentification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejectionCytokines required for induction of histocompatibility leukocyte antigen-class I-restricted and tumor-specific cytotoxic T lymphocytes by a SART1-derived peptideMulti-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma.Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.Interleukin-4 regulates eomesodermin in CD8+ T cell development and differentiation.Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.Spontaneous regression of neoplasms: new possibilities for immunotherapy.Gene therapy for malignant glioma.Functional role of IL-2 receptors on tumour-infiltrating lymphocytes.Human tumour-associated NK cells secrete increased amounts of interferon-gamma and interleukin-4Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptorDetection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLAIdentification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.A potent human interleukin-4 antagonist stimulates the proliferation of murine cells expressing the human interleukin-4 binding chain.T-cell recognition of human melanoma antigensPhenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapyThe clinical potential of recombinant human interleukin 4 and alfa-2b interferon.Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4.Interleukin-4 and cancer therapy.Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications.Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo.IL-1 and IL-4 as reciprocal regulators of IL-2 induced lymphocyte cytotoxicity.Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients.Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.Suppressive activity of interleukin 4 on the induction of antigen-specific cytotoxic T cells in humans.
P2860
Q24312048-33CD4747-FCBA-4E1E-A5FC-36709740A243Q24561706-08DE3ED9-7591-4734-BA24-811BE569F19BQ28146219-0DC426AB-3AD4-4183-B5A1-B1140944EE65Q33798623-9AE3AD76-72AA-4B7A-B01B-C521F363C024Q33908872-AAEE62A1-7E92-42DB-8A4A-D102B18111E5Q34160201-83E81A66-9E05-4A02-AB2E-730FE085B557Q34669675-54C00C72-8676-4692-83D4-30209C76BB6AQ34701352-A9D298E3-DE6F-4CAB-8A5C-2DE26C5B0513Q35673628-117C5D1F-52CA-4A81-8BFB-43D4CFF32825Q35979219-78AE6822-9415-4C6E-AA65-1AE7FD932B88Q35993694-1C91D495-C18A-42B1-B45E-EF030B9118EEQ36079678-E5AFE58A-5B5C-4B05-B07B-BF73C28A7CD1Q36080342-261035D4-9772-4CC6-8DB9-71C95FD5B36EQ36238343-8994FE13-0CDD-4A80-A513-CD5B6FA814E8Q36363449-0E0CDABA-ACEE-409B-A4D2-3F9B153EFC40Q36470734-233504C3-8553-420B-8B67-BE4BB49C0556Q36786931-124432ED-09FA-4F26-88A1-6859517E0D4FQ36914400-58BF161C-EBF3-408C-9F7D-112543151C21Q37107516-DE477F48-4E94-4A19-8BE0-97ADE42FDD0FQ37420702-4AE48D43-46BB-48FF-B3FE-49524C03B348Q40069517-BE8F9205-A2D9-49ED-9DB9-37C06FB4A1D3Q40822480-1B22A307-A75C-4CD7-BF22-3FB3DD4897FEQ40849487-042F87EC-1952-45F9-8735-74B0B4140E7EQ41969314-8122D597-C571-45A9-9EA0-FD1B860636A1Q42281642-D253FB5A-547B-4EAC-B43D-454C0C38F990Q43107256-8F1BB3A4-BC15-4C41-BB59-651DB1088B95Q45861094-D9C98193-2695-4A0C-8C59-3388AAD8E304Q55265276-8B22F6BB-7CAE-4B7E-9CEF-AAFAC40A195D
P2860
Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Interleukin 4 promotes the gro ...... for human autologous melanoma
@ast
Interleukin 4 promotes the gro ...... for human autologous melanoma
@en
type
label
Interleukin 4 promotes the gro ...... for human autologous melanoma
@ast
Interleukin 4 promotes the gro ...... for human autologous melanoma
@en
prefLabel
Interleukin 4 promotes the gro ...... for human autologous melanoma
@ast
Interleukin 4 promotes the gro ...... for human autologous melanoma
@en
P2093
P2860
P921
P356
P1476
Interleukin 4 promotes the gro ...... for human autologous melanoma
@en
P2093
Kawakami Y
Rosenberg SA
P2860
P304
P356
10.1084/JEM.168.6.2183
P407
P577
1988-12-01T00:00:00Z